AL101

Research Ayala's ex-BMS drug shows promise in triple-negative breast cancer
Fierce Biotech
Sun, 06/2/19 - 01:28 pm
ASCO 2019
Ayala Pharmaceuticals
Novartis
triple negative breast cancer
AL101
Novartis powers Notch cancer biotech Ayala to $30M series B
Fierce Biotech
Wed, 05/29/19 - 10:28 am
Novartis
Ayala Pharmaceuticals
AL101
adenoid cystic carcinoma